Redoxal
Redoxal is a novel prenyltransferase inhibitor exhibiting antibacterial efficacy in both in vitro and in vivo studies. It is a valuable research tool for investigating bacterial pathogenesis and developing new antimicrobial strategies targeting prenylation-dependent pathways.
Product Specifications
CAS Number
52962-95-5
Smiles
O=C (O) C=1C=CC=CC1NC2=CC=C (C=C2OC) C=3C=CC (NC=4C=CC=CC4C (=O) O) =C (OC) C3
Molecular Formula
C28H24N2O6
Molecular Weight
484.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1155642-01 0.02 mg (E-Coli)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details MBS1155642-02 0.1 mg (E-Coli)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details MBS1155642-03 0.02 mg (Yeast)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details MBS1155642-04 0.1 mg (Yeast)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details MBS1155642-05 0.02 mg (Baculovirus)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details MBS1155642-06 1 mg (E-Coli)
Recombinant Buthus occitanus israelis Lipolysis-activating peptide 1-beta chain
Sign In for Pricing
View Details